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OBJECTIVE: We investigated change in platelet activation using flow cytometry in patients before and
after splenectomy with total gastrectomy for gastric cancer.
METHODS: Six patients who underwent splenectomy for lymphadenectomy with total gastrectomy for
gastric cancer were the subjects in this study. In the patients, platelet count and platelet activation were
evaluated before the operation, 1 week after the operation, and 1 month after the operation. Expression
of CD62P (P-selectin) was analysed as a marker of platelet activation using flow cytometry.
RESULTS: Although platelet count significantly increased 1 week after the operation, the platelet count
1 month after the operation did not increase significantly. Expression of CD62P (P-selectin) significantly
decreased at 1 week and 1 month after the operation, compared with the level before the operation. 
No postoperative complications occurred in any patient.
CONCLUSION: In the present study, platelet activation did not progress after the operation. The results
mean that the risk of thrombosis after splenectomy does not increase. [Asian J Surg 2007;30(2):93–5]
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Introduction
Splenectomy for lymphadenectomy has often been per-
formed with total gastrectomy for gastric cancer. Since
the spleen is concerned with platelet count and platelet
function, increases in platelet count and abnormalities 
in platelet function are a cause of worry in almost all
patients after splenectomy.1 However, we could not find
any reports on the difference in platelet count and function
before and after splenectomy.
Platelet activation is useful for the clinical evaluation
of platelet function. It is important to detect platelet acti-
vation in vivo because platelet activation is concerned not
only with normal haemostasis but also with formation and
progress of various diseases, especially pathogenic throm-
bosis. Although the standard clinical test of platelet acti-
vation is platelet aggregometry, there are methodological
problems such as the influence of centrifugation or the
impossibility of quantitative analysis. The detection of
substances in plasma released by platelets is another test
for platelet activation. But the major problem with these
assays is the progress of release during blood collection
and plasma separation.2,3 Recently, antibodies for activation-
specific antigen on the platelet surface can be used for
detecting platelet activation by flow cytometry.3,4 This
method has many advantages, such as preventing the
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influence of centrifugation by fixing whole blood and 
to quantify activation-specific antigens on the platelet
surface and it is more useful in detecting platelet activa-
tion in vivo,5,6 it has detected platelet activation in various
diseases. In this pilot study, we investigated the change in
platelet activation by using the flow cytometry method
before and after splenectomy with total gastrectomy for
gastric cancer in patients.
Patients and methods
Between April 2004 and April 2005, six patients who
underwent splenectomy for lymphadenectomy with total
gastrectomy for gastric cancer were enrolled.
Five of the six patients were males. The median age was
61 years (range, 42–80 years). All of them underwent D2
lymphadenectomy and Roux-en-Y reconstruction.
Blood sample was obtained before operation, 1 week
after operation, and 1 month after operation. We measured
both the platelet activation and platelet count.
A Becton Dickinson FACScan was used for flow cyto-
metry to measure platelet activation. We used a mono-
clonal antibody (MAb) for an activation-specific antigen,
which is an α-granule membrane protein CD62P (P-selectin)
on the platelet surface for measuring the platelet surface
expression of CD62P (P-selectin). Values were represented
as the proportion of CD62P (P-selectin) antigen expression
to that before operation.
Blood was carefully drawn from an antecubital vein
through a 19-gauge needle and collected into a plastic
syringe containing 1.5 mg/mL disodium ethylenediamine-
tetraacetate (EDTA-2Na). The blood sample was then
fixed with 1% paraformaldehyde in phosphate-buffered
saline (PBS) for 2 hours at 4°C. After fixation, platelet-
rich plasma (PRP) was obtained by centrifugation at 100g
for 10 minutes at room temperature. The samples were
diluted 40 times with PBS. This diluted PRP (250 μL) was
incubated with 2 μL of phycoerythrin (PE)-conjugated
anti-CD62P (P-selectin) MAb (BD Biosciences) for 15
minutes at room temperature. After incubation, 10,000
platelets from each sample were analysed using a FAC-
Scan for platelet surface expression of CD62P (P-selectin).
Analysis of variance and Dunnett’s test were used for
the statistical analysis, with a risk ratio of less than 0.05
considered significant.
This study was performed following the Declaration
of Helsinki; all the patients were informed and consented
to participate in this study, and the study protocol was
approved by our hospital’s ethics committee.
Results
Platelet count increased significantly 1 week after opera-
tion compared with the level before operation (p = 0.01).
On the other hand, it was still higher than the level before
operation, but the increase in platelet count 1 month
after operation was not significant (Figure 1). Expression
of CD62P (P-selectin) was significantly lower 1 week after
operation (p < 0.001) and 1 month after operation (p =
0.03) than the level before operation. But it tended to
return to the level before operation 1 month after operation
(Figure 2).
No postoperative complications including thrombosis
occurred in any of the patients.
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Figure 1. Platelet count. Bars represent the mean ± standard
deviation. *p= 0.01, †p< 0.05 versus before the operation.
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Figure 2. Expression of CD62P (P-selectin). Bars represent the
mean ± standard deviation. Values are represented as CD62P 
(P-selectin) expression in proportion to that before operation.
*p< 0.001, †p= 0.003 versus before operation.
Discussion
The increase in expression of CD62P (P-selectin) in patients
with cerebral infarction and ischaemic heart disease has
been reported,7,8 and CD62P (P-selectin) expression was
significantly higher in patients with cerebral infarction
than in patients without cerebral infarction after heart valve
replacement.9 It was also reported that though the expres-
sion of activation-specific protein increased significantly,
there was no significant difference in the platelet counts
or levels of substances released from platelets in the dis-
eases related to abnormalities of platelet function. In short,
detecting substances in plasma released from platelets
and investigating platelet count are insufficient to evalu-
ate platelet activation. Murakami et al reported that flow
cytometric analysis of antigen on the platelet surface may
be more valid for the detection of platelet activation.8
The flow cytometry method measuring activation-
specific antigens on the platelet surface as a marker of
platelet activation was applied to determine platelet acti-
vation after stimulation by various platelet agonists. It
was reported that an increase in the expression of platelet
surface antigens was observed when platelets were acti-
vated.4,10 Further, expression of platelet surface antigens
increased in disease related to platelet activation.11 In this
study, CD62P (P-selectin) expression decreased and platelet
activation was suppressed after splenectomy.
Platelet count increased in almost all patients after
splenectomy with total gastrectomy in the perioperative
period. In the present study, platelet count increased sig-
nificantly 1 week after operation and tended to return to
the level before operation 1 month after operation. But it
remained higher than the level before operation.
Although an increase in platelet count was observed,
the expression of an activation-specific antigen decreased.
This showed that platelet activation was suppressed after
operation. From these results, increases in platelet count
and abnormalities of platelet function might not be a
cause for worry in almost all patients after splenectomy.
Though we have investigated only platelet count in
the perioperative period of splenectomy with total gas-
trectomy, the detection of platelet activation is important
as well. In all patients, in spite of a tendency for the
platelet count to return to the level before operation, the
platelet activation was recovered later. In future, we
intend to observe the progress until the condition returns
to that before operation and make a comparative study
between patients with and without splenectomy.
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